Medicare Enrolled
Dr. Daniel Harvey, MD
Family Medicine · Carson, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harvey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harvey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harvey
Dr. Daniel Harvey is a family medicine specialist in Carson, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Harvey performed 4,052 Medicare services across 763 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harvey received a total of $15,480 from 48 pharmaceutical and/or device companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harvey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in CA
$15,480 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,052
Medicare services
Top 4% in CA for family medicine
763
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~213 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
1,514 | $33 | $55 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
894 | $41 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
595 | $58 | $110 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
174 | $34 | $69 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
166 | $11 | $40 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
138 | $29 | $95 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
87 | $68 | $110 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
81 | $145 | $255 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
70 | $1 | $25 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
63 | $8 | $60 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
50 | $140 | $185 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
38 | $8 | $15 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
33 | $3 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $104 | $150 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
33 | $0 | $38 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
24 | $37 | $95 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
23 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
19 | $72 | $119 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 17 | $64 | $116 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,480
Total received (2018-2024)
Avg $2,211/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
497
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,480 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,571
2023
$1,252
2022
$1,550
2021
$2,518
2020
$1,588
2019
$2,261
2018
$4,741
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$337
Lilly USA, LLC
$252
Merck Sharp & Dohme LLC
$191
Novo Nordisk Inc
$158
AstraZeneca Pharmaceuticals LP
$137
Astellas Pharma US Inc
$125
Paratek Pharmaceuticals, Inc.
$70
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$52
Janssen Pharmaceuticals, Inc
$49
Bayer Healthcare Pharmaceuticals Inc.
$42
PFIZER INC.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Esperion Therapeutics, Inc.
$24
Exact Sciences Corporation
$19
Phadia US Inc.
$16
GlaxoSmithKline, LLC.
$14
Novartis Pharmaceuticals Corporation
$14
CeQur Corporation
$9
Top 3 companies account for 49.7% of 2024 payments
All-time payments by company (2018-2024) ›
Ironwood Pharmaceuticals, Inc
$3,389
Janssen Pharmaceuticals, Inc
$2,859
AstraZeneca Pharmaceuticals LP
$1,008
ABBVIE INC.
$824
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$610
Lilly USA, LLC
$573
Amarin Pharma Inc.
$506
Amgen Inc.
$502
Merck Sharp & Dohme LLC
$450
AbbVie Inc.
$442
Astellas Pharma US Inc
$402
Boehringer Ingelheim Pharmaceuticals, Inc.
$373
Allergan Inc.
$362
Sunovion Pharmaceuticals Inc.
$353
Merck Sharp & Dohme Corporation
$348
PFIZER INC.
$297
Vanda Pharmaceuticals Inc.
$274
Novo Nordisk Inc
$254
Allergan, Inc.
$240
Novartis Pharmaceuticals Corporation
$227
Paratek Pharmaceuticals, Inc.
$174
CMP Pharma, Inc.
$144
Smith+Nephew, Inc.
$135
BOSTON SCIENTIFIC CORPORATION
$88
GlaxoSmithKline, LLC.
$70
Abbott Laboratories
$52
Bayer HealthCare Pharmaceuticals Inc.
$49
Bayer Healthcare Pharmaceuticals Inc.
$42
Radius Health, Inc.
$42
Phadia US Inc.
$37
Nabriva Therapeutics, plc
$34
E.R. Squibb & Sons, L.L.C.
$31
SANOFI PASTEUR INC.
$28
Biohaven Pharmaceuticals, Inc.
$25
Esperion Therapeutics, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$23
Melinta Therapeutics, Inc.
$22
Orexigen Therapeutics, Inc.
$20
Exact Sciences Corporation
$19
Eisai Inc.
$18
Mannkind Corporation
$17
Biohaven Pharmaceutical Holding Company Ltd.
$16
Kowa Pharmaceuticals America, Inc.
$16
RedHill Biopharma Inc.
$15
Sanofi Pasteur Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Teva Pharmaceuticals USA, Inc.
$11
CeQur Corporation
$9
Top 3 companies account for 46.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · Aemcolo · Aimovig · BASAGLAR · BELSOMRA · BREZTRI · Baxdela · CHANTIX · COLLAGENASE SANTYL · CONTRAVE · Carospir · CeQur Simplicity · Cologuard Collection Kit · DALVANCE · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GENERAL PAIN MANAGEMENT · HETLIOZ · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · LANTUS · LATUDA · LEQVIO · LINZESS · LYRICA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · NUZYRA · Otezla · Ozempic · Prolia · QULIPTA · Repatha · SIVEXTRO · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Santyl · Sivextro · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · UBRELVY · VERQUVO · VESICARE · VIBERZI · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · Xenleta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
3,233
Per 100K population
32.8
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - SOUTH BAY
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harvey is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harvey experienced with nursing facility visit, established patient, straightforward?
Based on Medicare claims data, Dr. Harvey performed 1,514 nursing facility visit, established patient, straightforward services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harvey receive payments from pharmaceutical companies?
Yes. Dr. Harvey received a total of $15,480 from 48 companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harvey's costs compare to other family medicine physicians in Carson?
Dr. Harvey's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harvey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Carson
Browse family medicine physicians in Carson ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Ironwood Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ironwood Pharmaceuticals, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology